Today: 9 June 2026
Browse Category

NASDAQ:SOND 16 October 2025 - 21 November 2025

Epsium Enterprise (EPSM) Soars as Nasdaq Standout: Inside Today’s Wild Trading on 21 November 2025

Epsium Enterprise (EPSM) Soars as Nasdaq Standout: Inside Today’s Wild Trading on 21 November 2025

Epsium Enterprise Limited (NASDAQ: EPSM) surged 66% on Thursday, closing near $3.66, and continued volatile gains in pre-market trading on Friday, 21 November 2025. Various data sources showed EPSM up between 10% and 67% pre-market, with no official explanation for the spike. The Macau-based drinks distributor’s shares have gained roughly 165% over three days. EPSM’s market value reached about $49 million Friday morning.
21 November 2025
····
Sonder Holdings (SOND) Bankruptcy Latest: Chapter 7 Liquidation, Lawsuits and Stock Outlook – 20 November 2025

Sonder Holdings (SOND) Bankruptcy Latest: Chapter 7 Liquidation, Lawsuits and Stock Outlook – 20 November 2025

Sonder Holdings filed for Chapter 7 bankruptcy in Delaware after Marriott ended a 20-year licensing deal, triggering an immediate wind-down and global insolvency proceedings. SOND shares traded at $0.09 on November 20, down from a $1.9 billion valuation in 2022. A WARN Act class action alleges 1,000 employees were laid off without proper notice. Industry estimates say nearly 10,000 units are affected worldwide.
20 November 2025
···
Sonder Holdings (SOND) Nears Chapter 7 After Marriott Split: Stock & Bankruptcy Update for November 13, 2025

Sonder Holdings (SOND) Nears Chapter 7 After Marriott Split: Stock & Bankruptcy Update for November 13, 2025

Sonder Holdings is winding down operations and expects to file for Chapter 7 bankruptcy in the U.S., with insolvency proceedings abroad. Guests at its properties have reported being told to leave with little notice. SOND stock traded around $0.17 on Nov. 13, near record lows, after swinging between $0.20 and $0.37 on heavy volume. The company’s market cap has fallen to about $3 million from billions at its 2022 debut.
13 November 2025
··
Marriott Terminates Sonder Partnership After ‘Default’: Bonvoy Bookings Halted, 2025 Room‑Growth Outlook Trimmed

Marriott Terminates Sonder Partnership After ‘Default’: Bonvoy Bookings Halted, 2025 Room‑Growth Outlook Trimmed

Marriott International ended its licensing agreement with Sonder, citing a default by Sonder. Sonder properties have been removed from Marriott’s booking channels and are no longer part of Marriott Bonvoy. Marriott lowered its 2025 net rooms growth forecast to about 4.5% after removing Sonder inventory. The partnership began in 2024 and was intended to last 20 years.
9 November 2025
··
Sonder Holdings (SOND) Stock Skyrockets 50% After Q2 Earnings and New Partnership Surprise

Sonder Holdings (SOND) Stock Skyrockets 50% After Q2 Earnings and New Partnership Surprise

Sonder Holdings shares jumped over 50% in pre-market trading Oct. 16, rebounding from all-time lows under $1 after Q2 results showed revenue down 11% to $147.1 million and a net loss of $44.5 million. The company launched “Sonder Billing” for corporate clients and completed Marriott integration, but remains in financial distress with negative margins and ongoing bankruptcy risk.
16 October 2025
··

Stock Market Today

  • Nuvalent Shares Surge Near $124 Following GSK's $10.6 Billion Buyout Offer
    June 9, 2026, 10:35 AM EDT. Nuvalent's stock jumped 38.9% to $122.93 after GSK announced a $10.6 billion cash acquisition at $124 per share, reflecting a 40% premium to the last close. The deal highlights GSK's strategic move to expand its oncology portfolio beyond its current 6% share of sales, aiming to capitalize on Nuvalent's two lung cancer drugs pending FDA decisions this year. The tender offer needs the approval of at least half of Nuvalent's Class A shares and U.S. antitrust clearance. Early analyst reactions included target price adjustments but echoed caution over valuation. Nuvalent's pipeline products could face competition from existing ALK-targeted therapies by Pfizer and Roche.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Go toTop